BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 19767236)

  • 21. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy--topographic distribution and correlation with clinical and psychometric assessment.
    Hollerbach S; Kullmann F; Fründ R; Lock G; Geissler A; Schölmerich J; Holstege A
    Hepatogastroenterology; 1997; 44(16):1002-12. PubMed ID: 9261590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long latency auditory evoked potentials in schoolchildren and adolescents with epilepsy].
    Zgorzalewicz M
    Przegl Lek; 2006; 63 Suppl 1():8-13. PubMed ID: 17471817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased habituation of midlatency auditory evoked responses in Parkinson's disease.
    Teo C; Rasco L; al-Mefty K; Skinner RD; Boop FA; Garcia-Rill E
    Mov Disord; 1997 Sep; 12(5):655-64. PubMed ID: 9380045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Auditory P300 in the patients with traumatic brain injury].
    Cui Y; Liu F; Zhang XY; Tang P; Liu P; Zhang B; Liu JH
    Fa Yi Xue Za Zhi; 2009 Feb; 25(1):19-23. PubMed ID: 19397208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of prepulse inhibition do not depend on blink reflex excitability: a study in Parkinson's disease and Huntington's disease.
    Valls-Solé J; Muñoz JE; Valldeoriola F
    Clin Neurophysiol; 2004 Jul; 115(7):1527-36. PubMed ID: 15203054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short and long latency afferent inhibition in Parkinson's disease.
    Sailer A; Molnar GF; Paradiso G; Gunraj CA; Lang AE; Chen R
    Brain; 2003 Aug; 126(Pt 8):1883-94. PubMed ID: 12805105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [P300 and Parkinson disease. The role of cognitive changes].
    Sartucci F; Guerrini V; Tognoni G; Massetani R; Murri L; Muratorio A
    Riv Neurol; 1990; 60(6):229-33. PubMed ID: 2100048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of central motor functions using magnetic stimulation in Parkinson's disease.
    Diószeghy P; Hidasi E; Mechler F
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):101-5. PubMed ID: 10207679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [P300 in mild cognitive impairment and in dementia].
    Egerházi A; Glaub T; Balla P; Berecz R; Degrell I
    Psychiatr Hung; 2008; 23(5):349-57. PubMed ID: 19129551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of bilateral subthalamic deep brain stimulation on long-latency event-related potentials.
    Kovacs N; Balas I; Kellenyi L; Janszky J; Feldmann A; Llumiguano C; Doczi TP; Ajtay Z; Nagy F
    Parkinsonism Relat Disord; 2008 Aug; 14(6):476-80. PubMed ID: 18313971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Event-related potentials for response inhibition in Parkinson's disease.
    Bokura H; Yamaguchi S; Kobayashi S
    Neuropsychologia; 2005; 43(6):967-75. PubMed ID: 15716167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortical oscillations scan using chirp-evoked potentials in 6-hydroxydopamine rat model of Parkinson's disease.
    Pérez-Alcázar M; Nicolás MJ; Valencia M; Alegre M; López-Azcárate J; Iriarte J; Artieda J
    Brain Res; 2010 Jan; 1310():58-67. PubMed ID: 19931514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auditory temporal processing in Parkinson's disease.
    Guehl D; Burbaud P; Lorenzi C; Ramos C; Bioulac B; Semal C; Demany L
    Neuropsychologia; 2008; 46(9):2326-35. PubMed ID: 18439632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment correlates to low auditory event-related potential amplitudes in type 1 diabetes.
    Cooray GK; Maurex L; Brismar T
    Psychoneuroendocrinology; 2008 Aug; 33(7):942-50. PubMed ID: 18650025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary functions in Parkinson's disease.
    Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
    Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Habituation of auditory event-related potentials in patients with Behcet's disease.
    Kececi H; Kavak A; Akyol M; Degirmenci Y; Anul H
    Neurol Sci; 2004 Dec; 25(5):257-63. PubMed ID: 15624083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.